Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 as a minor internal update with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:16:29.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.1 with new dates (2026-02-04, 2026-01-15, 2026-01) and removal of 2025-12 entries.
    Difference
    0.1%
    Check dated 2026-02-08T11:29:35.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Added: a glossary toggle and metadata fields including 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus the Revision: v3.4.0. Removed: the field 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and the previous revision 'v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-25T08:29:59.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Footer revision text updated to show Revision: v3.3.4, replacing the old Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-18T06:40:56.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    - The page shows additions and deletions of date strings (e.g., 2025-12-23, 2025-12-04, 2025-12 and 2025-11-13, 2025-11-06, 2025-11), which appear to be update timestamps rather than alterations to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-27T23:09:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a new Locations section with an expanded list of study sites (Arizona, California, Colorado, Florida, Georgia, Louisiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Ontario, Quebec) and updated to Revision: v3.3.3; removed the prior per-state location subsections such as 'Arizona Locations' and 'California Locations'.
    Difference
    0.6%
    Check dated 2025-12-20T21:05:28.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.